Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119878703 | 11987870 | 3 | F | 20160916 | 20160202 | 20160919 | EXP | CA-ROCHE-1704003 | ROCHE | 56.00 | YR | F | Y | 0.00000 | 20160919 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119878703 | 11987870 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | U | 125276 | ||||||||||
| 119878703 | 11987870 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 119878703 | 11987870 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 119878703 | 11987870 | 4 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | U | 0 | 50 | MG | /wk | |||||||
| 119878703 | 11987870 | 5 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | U | 0 | ||||||||||
| 119878703 | 11987870 | 6 | SS | HCTZ | HYDROCHLOROTHIAZIDE | 1 | Unknown | U | 0 | ||||||||||
| 119878703 | 11987870 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | |||||||||||
| 119878703 | 11987870 | 8 | C | ARAVA | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 119878703 | 11987870 | 9 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Unknown | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119878703 | 11987870 | 1 | Product used for unknown indication |
| 119878703 | 11987870 | 2 | Product used for unknown indication |
| 119878703 | 11987870 | 3 | Rheumatoid arthritis |
| 119878703 | 11987870 | 4 | Rheumatoid arthritis |
| 119878703 | 11987870 | 6 | Product used for unknown indication |
| 119878703 | 11987870 | 7 | Rheumatoid arthritis |
| 119878703 | 11987870 | 8 | Rheumatoid arthritis |
| 119878703 | 11987870 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119878703 | 11987870 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119878703 | 11987870 | Allergic oedema | |
| 119878703 | 11987870 | Back pain | |
| 119878703 | 11987870 | Contusion | |
| 119878703 | 11987870 | Dermatitis allergic | |
| 119878703 | 11987870 | Drug hypersensitivity | |
| 119878703 | 11987870 | Drug ineffective | |
| 119878703 | 11987870 | Dysphagia | |
| 119878703 | 11987870 | Gait disturbance | |
| 119878703 | 11987870 | Hypertension | |
| 119878703 | 11987870 | Injection site bruising | |
| 119878703 | 11987870 | Injection site discolouration | |
| 119878703 | 11987870 | Injection site erythema | |
| 119878703 | 11987870 | Injection site hypersensitivity | |
| 119878703 | 11987870 | Injection site reaction | |
| 119878703 | 11987870 | Osteoarthritis | |
| 119878703 | 11987870 | Pain | |
| 119878703 | 11987870 | Pathological fracture | |
| 119878703 | 11987870 | Pruritus allergic | |
| 119878703 | 11987870 | Skin haemorrhage | |
| 119878703 | 11987870 | Spinal operation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |